10 Aug 2023 --- Atmo Biosciences launches a clinical study to assess the use of its Atmo gas capsule to measure the gastrointestinal transit time in patients with suspected motility disorders. This gas-sensing capsule provides insights into gut health and microbiome function, which can potentially support treatments for digestive issues like irritable bowel disease.
